Engineering in Cancer Biology and Therapy III: Drug Development and Delivery | AIChE

Other Sites & Tools

Technical Groups

Engineering in Cancer Biology and Therapy III: Drug Development and Delivery

Chair(s)

Ebong, E., Northeastern University

Co-chair(s)

Rao, S., University of Alabama

This session will cover a broad spectrum of approaches engineers have developed to understand and treat cancer. Abstracts could include include studies on fundamental biological processes involved in the development of cancer and in diagnosis or therapy of cancer. Experimental systems and computational approaches can range from microorganisms to mammalian cells to multi-cellular organisms (Drosophila and worms) and animal models, with a focus on the intersection between engineering and cancer.

Presentations

12:30 PM
(137a) Diffusion-Based Delivery of Alpha-Particle Radiotherapeutics Effectively Controls Recurrent, Chemoresistant Triple Negative Breast Cancer
12:48 PM
(137b) Novel Cytostatic Annexin A5-Drug Conjugates for Cancer Treatment
1:06 PM
(137c) Synergistic and Multimodal Cancer Gene Therapy Using Viral/Nonviral Chimeric Vectors
1:24 PM
(137d) Silica Gel Encapsulation of Ovarian Cancer Cells for Selection of Cells Exhibiting Both a Higher Propensity to Enter Quiescence and Enhanced Chemoresistance
1:42 PM
(137e) High Diffusive Peptides for Drug Carriers in Tumor Extracellular Matrix
2:00 PM
(137f) Longitudinal Tracking of Single Cells Reveals Drug Resistant Phenotypes in Cancer
2:18 PM
(137g) Invited: Engineering Targeted Drug Delivery Vehicles

Topics 

Biological Engineering

Checkout

Paper abstracts are public but to access Extended Abstracts, you must first purchase the conference proceedings.

Checkout

Do you already own this?

Pricing

Individuals

AIChE Pro Members $150.00
AIChE Graduate Student Members Free
AIChE Undergraduate Student Members Free
AIChE Explorer Members $225.00
Non-Members $225.00

More Conference Links